Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study.
Donaldson SH, Corcoran TE, Pilewski JM, Laube BL, Mogayzel P, Ceppe A, Wu J, Zeman K, Rowe SM, Nichols DP, Gifford AH, Bennett WD, Mayer-Hamblett N; SIMPLIFY MCC Study teams. Donaldson SH, et al. Among authors: laube bl. J Cyst Fibros. 2024 Feb 13:S1569-1993(24)00018-3. doi: 10.1016/j.jcf.2024.02.003. Online ahead of print. J Cyst Fibros. 2024. PMID: 38355350
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study.
Donaldson SH, Laube BL, Mogayzel P, Corcoran TE, Pilewski JM, Ceppe A, Wu J, Bhambhvani PG, Ratjen F, Sagel SD, Clancy JP, Rowe SM, Bennett WD. Donaldson SH, et al. Among authors: laube bl. J Cyst Fibros. 2022 Jan;21(1):143-145. doi: 10.1016/j.jcf.2021.05.004. Epub 2021 May 31. J Cyst Fibros. 2022. PMID: 34083123 Free PMC article.
Characterizing mucociliary clearance in young children with cystic fibrosis.
Laube BL, Carson KA, Evans CM, Aksit MA, Collaco JM, Richardson VL, Sharpless G, Zeitlin PL, Cutting GR, Mogayzel PJ. Laube BL, et al. Pediatr Res. 2022 Feb;91(3):612-620. doi: 10.1038/s41390-021-01453-2. Epub 2021 Mar 22. Pediatr Res. 2022. PMID: 33753897 Free PMC article.
Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTR.
Donaldson SH, Laube BL, Corcoran TE, Bhambhvani P, Zeman K, Ceppe A, Zeitlin PL, Mogayzel PJ Jr, Boyle M, Locke LW, Myerburg MM, Pilewski JM, Flanagan B, Rowe SM, Bennett WD. Donaldson SH, et al. Among authors: laube bl. JCI Insight. 2018 Dec 20;3(24):e122695. doi: 10.1172/jci.insight.122695. JCI Insight. 2018. PMID: 30568035 Free PMC article.
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing.
Hallstrand TS, Leuppi JD, Joos G, Hall GL, Carlsen KH, Kaminsky DA, Coates AL, Cockcroft DW, Culver BH, Diamant Z, Gauvreau GM, Horvath I, de Jongh FHC, Laube BL, Sterk PJ, Wanger J; American Thoracic Society (ATS)/European Respiratory Society (ERS) Bronchoprovocation Testing Task Force. Hallstrand TS, et al. Among authors: laube bl. Eur Respir J. 2018 Nov 15;52(5):1801033. doi: 10.1183/13993003.01033-2018. Print 2018 Nov. Eur Respir J. 2018. PMID: 30361249 Free article.
ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen; Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ. Coates AL, et al. Among authors: laube bl. Eur Respir J. 2017 May 1;49(5):1601526. doi: 10.1183/13993003.01526-2016. Print 2017 May. Eur Respir J. 2017. PMID: 28461290 Free article.
Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products.
Newman S, Bennett WD, Biddiscombe M, Devadason SG, Dolovich MB, Fleming J, Haeussermann S, Kietzig C, Kuehl PJ, Laube BL, Sommerer K, Taylor G, Usmani OS, Zeman KL. Newman S, et al. Among authors: laube bl. J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S10-28. doi: 10.1089/jamp.2012.1Su4. J Aerosol Med Pulm Drug Deliv. 2012. PMID: 23215844
Editorial: Standards for lung imaging techniques.
Laube BL, Corcoran TE, Devadason SG, Dolovich MB, Fleming J, Newman S. Laube BL, et al. J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S1-2. doi: 10.1089/jamp.2012.1Su1. J Aerosol Med Pulm Drug Deliv. 2012. PMID: 23215843 No abstract available.
What the pulmonary specialist should know about the new inhalation therapies.
Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H; European Respiratory Society; International Society for Aerosols in Medicine. Laube BL, et al. Eur Respir J. 2011 Jun;37(6):1308-31. doi: 10.1183/09031936.00166410. Epub 2011 Feb 10. Eur Respir J. 2011. PMID: 21310878 Free article.
Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report.
Adams WP, Ahrens RC, Chen ML, Christopher D, Chowdhury BA, Conner DP, Dalby R, Fitzgerald K, Hendeles L, Hickey AJ, Hochhaus G, Laube BL, Lucas P, Lee SL, Lyapustina S, Li B, O'Connor D, Parikh N, Parkins DA, Peri P, Pitcairn GR, Riebe M, Roy P, Shah T, Singh GJ, Sharp SS, Suman JD, Weda M, Woodcock J, Yu L. Adams WP, et al. Among authors: laube bl. J Aerosol Med Pulm Drug Deliv. 2010 Feb;23(1):1-29. doi: 10.1089/jamp.2009.0803. J Aerosol Med Pulm Drug Deliv. 2010. PMID: 20131983
Gene therapy in cystic fibrosis.
Flotte TR, Laube BL. Flotte TR, et al. Among authors: laube bl. Chest. 2001 Sep;120(3 Suppl):124S-131S. doi: 10.1378/chest.120.3_suppl.124s. Chest. 2001. PMID: 11555567 Review.